The National Basket of Health Services, known in Hebrew as Sal HaBriut, represents the cornerstone of Israel’s universal healthcare system. Established as a statutory guarantee, it mandates that all Israeli residents have access to a comprehensive set of medical services, medications, and treatments. To keep pace with rapid clinical innovations, the state utilizes an objective, multi-disciplinary body known as the Public Committee for the Expansion of the Health Services Basket. This committee is tasked with the complex responsibility of updating the basket annually, ensuring that Israel's citizens benefit from cutting-edge medical care.
Origins of the National Health Insurance Law
The foundation of modern Israeli healthcare was laid with the passage of the National Health Insurance Law of 1994, which officially went into effect in January 1995. Prior to this landmark legislation, healthcare was managed by fragmented, labor-union-affiliated sick funds without uniform service standards. The 1994 law completely restructured the system, requiring every citizen to register with one of four non-profit health maintenance organizations, known as Kupot Holim. Crucially, the law codified a standardized "basket" of medical benefits that these funds are legally obligated to provide to every member.
Because medical science is constantly evolving, the original 1995 basket quickly required mechanism adjustments to incorporate new drugs and therapeutic procedures. To prevent the stagnation of clinical coverage, Israeli policymakers designed an annual legislative and administrative mechanism to systematically expand the basket. This process relies on a separate, dedicated budgetary allocation from the Ministry of Finance, which is determined during national budget negotiations. By establishing this formal path for growth, the state ensures that the healthcare safety net remains clinically modern rather than frozen in its historical baseline.
The Technology Prioritization Committee and Evaluation Framework
The Public Committee for the Expansion of the Health Services Basket serves as the primary decision-making body for integrating new medical technologies. Appointed by the Ministers of Health and Finance, this committee is deliberately structured to reflect a broad spectrum of expert and public interests. Its members include leading senior physicians, healthcare economists, representatives from the Ministry of Health and Ministry of Finance, public figures, ethicists, and executives from the four competitive health funds. This diverse coalition ensures that clinical merit, economic feasibility, social equity, and ethical dilemmas are balanced during intensive deliberations.
Before the public committee begins its annual debate, the Health Basket Technology Evaluation Division of the Ministry of Health performs rigorous preparatory work. This administrative division receives hundreds of detailed requests from pharmaceutical companies, medical societies, and patients seeking the inclusion of new therapies. Experts within the division conduct thorough health technology assessments to analyze clinical trial data, relative efficacy, safety profiles, and cost-effectiveness. This critical, evidence-based preparation allows the committee to focus its energy on prioritizing pre-vetted, clinically viable options within the defined budget limits.
Key Facts of the Health Basket System
- Annual Budget Allocation: The national government provides a specific, designated budget for the expansion of the basket each year, which has reached 650 million NIS for the 2026 funding cycle.
- High Volume of Submissions: The committee routinely evaluates between 600 and 900 individual drug and technology submissions annually, ultimately approving only a fraction that meet the highest standards of cost-utility.
- Universal HMO Coverage: Any medical service or drug successfully approved and added to the National Health Basket must be made available to all eligible residents by all four Kupot Holim.
Analysis of the Prioritization Methodology
The methodology employed by Israel's Health Basket Committee is widely studied as a model of evidence-informed deliberative processes. Because the demand for cutting-edge medical technologies always exceeds the national budget, the committee must navigate intense ethical, social, and economic choices. They utilize a multi-criteria decision analysis framework, which factors in severity of disease, patient population size, alternative clinical solutions, and the cost of implementation. To review information regarding these strategic state updates, visit the official Israeli Ministry of Health portal, which hosts direct links to historical committee decisions and annual expansion budgets.
A key strength of this approach is its ability to negotiate deep discounts with global pharmaceutical manufacturers due to the centralized purchasing power of the state. By consolidating the national demand into a single negotiating mandate, the state maximizes the public utility of every shekel spent. Peer-reviewed studies published in Health Technology Assessment (HTA) research demonstrate how Israel's model successfully guarantees early access to orphan drugs and oncology therapies relative to other developed nations. To maintain transparency, the Ministry of Health routinely publishes its detailed selections online through Official Ministry of Health Announcements, which outlines the specific clinical rationale behind each newly funded therapy.
National Significance and Healthcare Outcomes
The National Basket of Health Services has a profound effect on reducing health disparities across diverse demographic sectors within Israel. By decoupling access to life-saving treatments from an individual's personal socio-economic status, the state preserves health equity as a basic human right. This centralized system also enables outstanding public health tracking, as the four HMOs implement the basket uniformly, gathering robust epidemiological data. Ultimately, the systematic modernization of Sal HaBriut remains one of the primary reasons Israel consistently ranks among the top global economies in overall life expectancy and healthcare quality.